Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Parkinson’s Disease Foundation Announces New Members of People with Parkinson’s Advisory Council

The Parkinson’s Disease Foundation® (PDF®) is pleased to announce new members of its People with Parkinson’s Advisory Council. The council is made up of people living with Parkinson’s disease and care partners who help drive PDF’s goals of ending the disease and supporting those affected by it.

“PDF exists to meet the needs of the Parkinson’s disease community, but we can only do that if we ask for guidance from those we serve,” says PDF President Robin Elliott. “We welcome our newest advisors, knowledgeable patient leaders who have the expertise to help us more effectively improve the lives and futures of people touched by Parkinson’s disease.”

Advisory council members guide PDF’s mission and priorities; identify and solve unmet needs; provide input on programs; and serve as liaisons to the community. The advisory council has steered PDF toward its most critical programs, including its annual Community Choice Research Awards, which seek feedback from the patient community on scientific research. Additionally, its members have played a vital role in the development of educational materials to help inform their peers, including PDF’s popular Parkinson’s Disease Resource List and its educational webinars.

The advisory council’s newest members, all of whom live with Parkinson's disease, represent a wide range of communities, professional skills and personal experiences. They include the following individuals:

Julio Angulo, Ph.D., of Mesa, AZ: a retired clinical and forensic psychologist, who ran his own private practice for more than 30 years.

Girija Muralidhar, Ph.D., of Poway, CA: a retired research scientist who worked in the field of immunology for 30 years to develop new vaccines and treatments.

Daniel Novak, Ph.D., of Fort Worth, TX: an executive coach and assistant professor of business administration who spent 30 years in executive roles at IBM.

A.C. Woolnough, of Sandpoint, ID: a retired high school principal and English teacher with more than 35 years of experience in education in Alaska, Idaho and California.

Alan B. Zimmerman, of Knoxville, TN: a veteran of the US Navy, and a retired real estate broker and small business owner.

“As members of the PDF People with Parkinson’s Advisory Council, we understand more than anyone the realities of the disease and the urgency to find better treatments and a cure. We can and will work tirelessly on behalf of the one million Americans who live with Parkinson’s disease to ensure PDF’s programs meet their needs and priorities,” added Linda Morgan, M.B.A., R.Ph., of Asheville, NC, Chair of the advisory council.

Ms. Morgan remains Chair of the advisory council and a member of the PDF Board of Directors. Karen Smith, of Evansville, IN, remains Vice Chair of the advisory council.

Tuesday, May 12, 2015
In Memory of Robert Traurig
Wednesday, July 18, 2018

The Parkinson’s Foundation mourns the loss of emeritus board member Robert (Bob) Traurig. From 2004 to 2015, he was a member of the Foundation’s board of directors. Bob is survived by his wife Jacqueline, his daughters Madeline Sackel and Wendy Traurig.

New Study Shows 1.2 Million People in the United States Estimated to be Living with Parkinson’s Disease by 2030
Tuesday, July 10, 2018

Parkinson’s Foundation Reveals Most Comprehensive Estimate of
Parkinson’s Prevalence in North America since the 1970’s

Parkinson’s Foundation Elects Howard D. Morgan Chairman of the Board
Tuesday, June 26, 2018

MIAMI & NEW YORK — June 26, 2018 — The Parkinson’s Foundation today announced the election of Howard D. Morgan as chairman of its board of directors. Mr. Morgan, who previously served as the Vice Chair of the nonprofit organization’s board, is a Partner and the Senior Managing Director of Argand Partners in New York.

Parkinson’s Foundation Announces Five New Members of its People with Parkinson’s Advisory Council
Wednesday, June 13, 2018

NEW YORK & MIAMI — June 13, 2018 — The Parkinson’s Foundation today announced five new members of its People with Parkinson’s Advisory Council.

The Parkinson’s Foundation 2018 Gala in New York City Tuesday, May 8, 2018
Monday, May 14, 2018

The Parkinson’s Foundation 2018 Gala was held at Cipriani 25 Broadway in New York City on Tuesday, May 8, 2018.

Parkinson’s Foundation Adds Alison Herman to its Board of Directors
Tuesday, May 8, 2018

MIAMI – May 9, 2018 – The Parkinson’s Foundation today announced the election of Alison Herman to its board of directors. Herman is senior counsel at Southern Glazer’s Wine & Spirits, a company which has generously supported Parkinson’s Foundation fundraisers.

Statement on Nuplazid Drug
Tuesday, April 10, 2018

On 4/9/18, CNN published an article on the FDA-approved drug, Nuplazid, used to treat hallucinations and psychosis in Parkinson’s disease. The article investigates FDA data showing the number of reported deaths with people taking Nuplazid. Nuplazid was approved by the FDA in 2016 and is manufactured by Acadia Pharmaceuticals.

Parkinson’s Foundation Adds John D. Thomopoulos to its Board of Directors
Monday, March 19, 2018

MIAMI & NEW YORK – March 19, 2018 – The Parkinson’s Foundation today announced the election of John D. Thomopoulos to its board of directors. Thomopoulos is a partner at Ernst & Young.

In Memory of Edythe Kay Marsa
Monday, March 12, 2018

The Parkinson’s Foundation mourns the loss of emeritus board member, Edythe (Edy) Kay Marsa. From 1993 to 2014, she was a member of the Foundation’s board of directors and served on several committees. Edy is survived by her husband William Marsa, who founded the Herbert Kay Parkinson Chapter in honor of her first husband who passed away due to complications from Parkinson’s disease.

Parkinson’s Foundation Announces New Genetic Initiative Connecting Parkinson’s Genetic Data with Clinical Care
Tuesday, March 6, 2018

MIAMI & NEW YORK—March 6, 2018—The Parkinson’s Foundation today announced a new initiative offering genetic testing and counseling to Parkinson’s patients within its Center of Excellence network.


mail icon

Subscribe to get the latest news on treatments, research and other updates.